by Single cell genome sequencing allows researchers to analyze changes in DNA, RNA and protein expression of individual cells, which has led to discoveries of new cell types and advances in reproductive health, immunology and cancer research. By automatically preparing samples, the process is streamlined allowing for large-scale analysis.
The global Single Cell Genome Sequencing Market is estimated to be valued at US$ 2.28 billion in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Automated sample preparation is revolutionizing single cell genome sequencing through increased throughput and reproducibility. Formerly a lengthy manual process, automated liquid handlers can now isolate thousands of individual cells and prepare them for sequencing in an efficient manner. This has democratized the technology by making it accessible for large cohort studies. Early applications focused on specific cell types like cancer or neurons, but automation is now enabling genome-wide surveys of entire tissues and organs. Researchers are leveraging the massively parallel insights to gain a system-level understanding of how genes and cellular environments interact to drive development, disease and responses to therapy.
SWOT Analysis
Strength: Single cell genome sequencing allows for comprehensive analysis of individual cells which provides valuable insights into complex cell populations. It helps understand genetic variations within tissues and tumours.
Weakness: Single cell genome sequencing requires sophisticated equipment and expertise which increases the costs of analysis. Low sample throughput and lack of standard sequencing protocols also limits widespread adoption.
Opportunity: Rapidly evolving technologies are improving efficiencies, reducing costs and increasing sequencing throughput. Growing incidence of cancer and other diseases is driving demand for advanced diagnostic tools.
Threats: Ethical issues related to the analysis and storage of genomic data needs to be addressed. Intense competition from emerging players can saturate the market.
Key Takeaways
Global Single Cell Genome Sequencing Market Size is expected to witness high growth. The global Single Cell Genome Sequencing Market is estimated to be valued at US$ 2.28 billion in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023-2030.
North America currently dominates the market due to presence of leading technology developers and availability of funding for research. Growing incidence of genetic disorders and cancer is further driving adoption in the region.
Key players operating in the single cell genome sequencing market are 10x Genomics, BGI, Fluidigm Corporation, Illumina, 1CellBio, MissionBio, Novogene Corporation, Oxford Nanopore Technologies and QIAGEN N.V. These players are focusing on developing advanced tools and kits for high throughput sequencing at reduced costs. Strategic collaborations with research institutes are helping them expand into new applications.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
